VENROCK ASSOCIATES II LP

CIK 00012392435 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001239243

Recent Transactions

50 trades

Other
XENOPORT INC
Series D Preferred Stock
2005-06-07+4,194→ 102,527 total
Other
XENOPORT INC
Series D Preferred Stock
2005-06-07+4,194→ 102,527 total
Conversion
XENOPORT INC
Series D Preferred Stock
2005-06-07−102,527→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+102,527→ 836,900 total
Conversion
XENOPORT INC
Series B Preferred Stock
2005-06-07−346,920→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+236,000→ 269,453 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+118,000→ 734,373 total
Conversion
XENOPORT INC
Series A Preferred Stock
2005-06-07−236,000→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+346,920→ 616,373 total
Conversion
XENOPORT INC
Series D Preferred Stock
2005-06-07−102,327→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+102,327→ 836,700 total
Conversion
XENOPORT INC
Series C Preferred Stock
2005-06-07−118,000→ 0 total
Conversion
XENOPORT INC
Series C Preferred Stock
2005-06-07−118,000→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+102,327→ 836,700 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+236,000→ 269,453 total
Conversion
XENOPORT INC
Series A Preferred Stock
2005-06-07−236,000→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+346,920→ 616,373 total
Conversion
XENOPORT INC
Series D Preferred Stock
2005-06-07−102,327→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+118,000→ 734,373 total
Conversion
XENOPORT INC
Series B Preferred Stock
2005-06-07−346,920→ 0 total
Conversion
XENOPORT INC
Common Stock
2005-06-07+102,527→ 836,900 total
Conversion
XENOPORT INC
Series D Preferred Stock
2005-06-07−102,527→ 0 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+73,751→ 855,371 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+217,120→ 781,620 total
Conversion
ICAGEN INC
Series G-1 Convertible Preferred Stock
2005-02-08−73,751→ 0 total
Conversion
ICAGEN INC
Series D Convertible Preferred Stock
2005-02-08−538,909→ 0 total
Conversion
ICAGEN INC
Series H Convertible Preferred Stock
2005-02-08−110,625→ 0 total
Conversion
ICAGEN INC
Series F Convertible Preferred Stock
2005-02-08−217,120→ 0 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+110,625→ 965,996 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+538,909→ 564,500 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+73,751→ 855,371 total
Conversion
ICAGEN INC
Series F Convertible Preferred Stock
2005-02-08−217,120→ 0 total
Conversion
ICAGEN INC
Series H Convertible Preferred Stock
2005-02-08−110,625→ 0 total
Conversion
ICAGEN INC
Series G-1 Convertible Preferred Stock
2005-02-08−73,751→ 0 total
Conversion
ICAGEN INC
Series D Convertible Preferred Stock
2005-02-08−538,909→ 0 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+538,909→ 564,500 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+217,120→ 781,620 total
Conversion
ICAGEN INC
Common Stock
2005-02-08+110,625→ 965,996 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−823,256→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+271,428→ 271,428 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+201,555→ 472,983 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+274,418→ 747,401 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−566,400→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−823,256→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−566,400→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+274,418→ 747,401 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+271,428→ 271,428 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+201,555→ 472,983 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series B Convertible Preferred Stock
2004-04-08−814,286→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series B Convertible Preferred Stock
2004-04-08−814,286→ 0 total

Companies

Recent Filings

Address

3340 HILLVIEW AVENUE

PALO ALTO, CA, 94304

View on SEC.gov